Fungal infections are an important and increasing global threat, carrying not only high morbidity and mortality rates, but also extraordinary healthcare costs. Without an effective response, it is predicted that 10 million people will die per year because of multidrug-resistant pathogens. A high percentage of the mortalities caused by fungi are known to have a biofilm etiology [1,2,3,4]. In fact, biofilms are the predominant mode of fungal growth. They have several ecologic benefits, for example higher nutrient availability, metabolic cooperation, protection from the environmental stresses, and acquisition of new and advantageous features. Besides, single-species and mixed-species biofilms are particularly problematic to eradicate, being, thus, the foundation of chronic infections, particularly if medical devices are existent [5].
A total of ten papers were published in this Special Issue including three reviews and six original articles. These cover a wide range of topics with original research on polymicrobial biofilms of fungi and bacteria, small molecule screening, characterization of the impact of current antifungals on biofilms of non-albicans species, characterization of non-albicans species biofilm matrix, and biofilms of Aspergillus fumigatus. Additionally, review articles cover the antifungal effect of quorum sensing molecules on Candida biofilms, sexual biofilms of Candida albicans, and a compilation of plant derived compounds and their activities against biofilms formed by Candida species.
The reports describe original research in the area of antimicrobials and include work involving individual and combinatorial efficacy of compounds with specific activity against fungi, bacteria, or both within polymicrobial biofilms [6], a screen of a small molecule library alone or in combination with current antifungals in search of compounds with anti-biofilm and pre-formed biofilm activities [7], characterization of the effect of echinocandins against planktonic and biofilm lifestyles of clinical isolates from the Candida haemulonii complex [8], and the use of a membranotropic peptide to disrupt polymicrobial biofilms of Candida albicans and Klebsiella pneumoniae [9]. Additional reports phenotypically characterized colonies from Candida parapsilosis clinical isolates as a way to predict their biofilm formation capabilities [10], conducted analyses of the biofilm matrix composition from the Candida haemulonii species complex [11], and investigated the virulence and biofilm capabilities of an Aspergillus fumigatus environmental isolate with interest in the role of this isolate in the textile industry [12].
The reviews in this Special Issue covered recent developments in the area of Candida albicans sexual biofilms specifically focusing on how they are formed, their physical characteristics, and their role in Candida biology [13], the properties of the quorum sensing molecules farnesol and tyrosol secreted by Candida and their effect as anti-biofilm agents [14], and an extensive compilation of plant derived compounds with activities against biofilms of distinct Candida species [15]. Overall, this Special Issue is a great resource highlighting novel work on fungal biofilms.
Acknowledgments
C.F.R. would like to acknowledge the UID/EQU/00511/2020 Project—Laboratory of Process Engineering, Environment, Biotechnology and Energy (LEPABE)—financed by national funds through FCT/MCTES (PIDDAC).
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Ivanova K., Ramon E., Hoyo J., Tzanov T. Innovative Approaches for Controlling Clinically Relevant Biofilms: Current Trends and Future Prospects. Curr. Top. Med. Chem. 2017;17:1889–1914. doi: 10.2174/1568026617666170105143315. [DOI] [PubMed] [Google Scholar]
- 2.Costerton J.W., Cheng K.J., Geesey G.G., Ladd T.I., Nickel J.C., Dasgupta M., Marrie T.J. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 1987;41:435–464. doi: 10.1146/annurev.mi.41.100187.002251. [DOI] [PubMed] [Google Scholar]
- 3.Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284:1318–1322. doi: 10.1126/science.284.5418.1318. [DOI] [PubMed] [Google Scholar]
- 4.Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: From the natural environment to infectious diseases. Nat. Rev. Microbiol. 2004;2:95–108. doi: 10.1038/nrmicro821. [DOI] [PubMed] [Google Scholar]
- 5.Santos A., Galdino A.C.M., Mello T.P., Ramos L.S., Branquinha M.H., Bolognese A.M., Columbano Neto J., Roudbary M. What are the advantages of living in a community? A microbial biofilm perspective! Mem. Inst. Oswaldo Cruz. 2018;113:e180212. doi: 10.1590/0074-02760180212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lobo C.I.V., Lopes A., Klein M.I. Compounds with Distinct Targets Present Diverse Antimicrobial and Antibiofilm Efficacy against Candida albicans and Streptococcus mutans, and Combinations of Compounds Potentiate Their Effect. J. Fungi. 2021;7:340. doi: 10.3390/jof7050340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lohse M.B., Ennis C.L., Hartooni N., Johnson A.D., Nobile C.J. A Screen for Small Molecules to Target Candida albicans Biofilms. J. Fungi. 2020;7:9. doi: 10.3390/jof7010009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ramos L.S., Silva L.N., Branquinha M.H., Santos A.L.S. Susceptibility of the Candida haemulonii Complex to Echinocandins: Focus on Both Planktonic and Biofilm Life Styles and a Literature Review. J. Fungi. 2020;6:201. doi: 10.3390/jof6040201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Maione A., de Alteriis E., Carraturo F., Galdiero S., Falanga A., Guida M., Di Cosmo A., Maselli V., Galdiero E. The Membranotropic Peptide gH625 to Combat Mixed Candida albicans/Klebsiella pneumoniae Biofilm: Correlation between In Vitro Anti-Biofilm Activity and In Vivo Antimicrobial Protection. J. Fungi. 2021;7:26. doi: 10.3390/jof7010026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gomez-Molero E., De-la-Pinta I., Fernandez-Pereira J., Gross U., Weig M., Quindos G., de Groot P.W.J., Bader O. Candida parapsilosis Colony Morphotype Forecasts Biofilm Formation of Clinical Isolates. J. Fungi. 2021;7:33. doi: 10.3390/jof7010033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ramos L.S., Mello T.P., Branquinha M.H., Santos A.L.S. Biofilm Formed by Candida haemulonii Species Complex: Structural Analysis and Extracellular Matrix Composition. J. Fungi. 2020;6:46. doi: 10.3390/jof6020046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Rebaza T.D., Ludena Y., Samolski I., Villena G.K. Gene Expression Analysis of Non-Clinical Strain of Aspergillus fumigatus (LMB-35Aa): Does Biofilm Affect Virulence? J. Fungi. 2020;6:376. doi: 10.3390/jof6040376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Perry A.M., Hernday A.D., Nobile C.J. Unraveling How Candida albicans Forms Sexual Biofilms. J. Fungi. 2020;6:14. doi: 10.3390/jof6010014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kovacs R., Majoros L. Fungal Quorum-Sensing Molecules: A Review of Their Antifungal Effect against Candida Biofilms. J. Fungi. 2020;6:99. doi: 10.3390/jof6030099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Karpinski T.M., Ozarowski M., Seremak-Mrozikiewicz A., Wolski H., Adamczak A. Plant Preparations and Compounds with Activities against Biofilms Formed by Candida spp. J. Fungi. 2021;7:360. doi: 10.3390/jof7050360. [DOI] [PMC free article] [PubMed] [Google Scholar]